The Food and Drug Administration (FDA) approved a prescription nasal spray this week that can reverse opioid overdoses. Opvee ...

The approval comes nearly two months after the U.S. health regulator approved the prescription-free sale of Emergent Biosolutions' Narcan nasal spray, which is a naloxone-based drug used to reverse ...

The FDA approved Opvee nalmefene hydrochloride nasal spray for the emergency treatment of opioid overdoses from Opiant ...

The FDA has approved Emergent's over-the-counter Narcan, a drug to treat opioid overdoses. OTC Narcan can contribute significantly to combatting the escalating opioid crisis in the U.S. The OTC ...

The U.S. Food and Drug Administration (FDA) has approved the use of a new form of gene therapy that targets a rare inherited eye disease. The FDA panel had voted to approve the therapy back in ...

FDA Approves Methylphenidate Patch for Teens With ADHD The FDA has approved an expanded age range for a methylphenidate transdermal system for the treatment of ADHD in adolescents aged 13 to 17 years.

It’s not yet clear how the drug will be used differently than naloxone, and some experts see downsides to its longer-acting ...

U.S. health regulators on Monday approved a new easy-to-use version of a medication to reverse overdoses caused by fentanyl ...

FDA Approves Tapentadol for Chronic Pain Tapentadol extended release, already approved for acute pain, has now been given the go ahead for chronic pain. News, August 26, 2011 FDA Approves New Drug ...

The U.S. Food and Drug Administration on Monday approved a second nasal spray for reversing an opioid overdose. To be sold as Opvee, the spray contains the medication nalmefene hydrochloride and will ...

U.S. health regulators on Monday approved a new easy-to-use version of a medication to reverse overdoses caused by fentanyl ...

The Food and Drug Administration on Monday said that it had given regulatory approval to a nasal spray that has proven ...